Nurse Practitioner · Houston, TX
NPI
1205592243
Since 2021
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1515 Holcombe Blvd
Houston, TX, 77030
Phone (713) 792-6161
Groups this clinician bills Medicare through
Medicare paid, 2024
$5,970
163 services
Medicare patients, 2024
122
Average age 73
Drug cost, 2024
$3.1M
457 prescriptions
Company payments, 2024
$624
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Robin Cook was code 99213 (office e&m - established), 54 times for 44 patients. In total Robin Cook billed 163 services in 6 codes, and Medicare paid $5,970.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-02-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Facility | 54 | 44 | $44.71 | $2,414 |
| 99441 Telephone Services | Facility | 32 | 23 | $22.19 | $710 |
| 38222 Other Organ Systems | Facility | 28 | 28 | $43.55 | $1,220 |
| 99213 Office E&M - Established | Office | 25 | 16 | $31.12 | $778 |
By year: 2022 $13K for 322 services; 2023 $13K for 301 services; 2024 $5,970 for 163 services.
Medicare prescription drug claims, 2024
In 2024, the drug Robin Cook prescribed most often to Medicare patients was Valacyclovir (Valacyclovir Hcl), with 40 prescriptions and refills. In total Robin Cook wrote 457 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Valacyclovir Valacyclovir Hcl | 40 | 66 | 11 | $1,043 |
| Inqovi Decitabine/Cedazuridine | 36 | 36 | Under 11 | $247K |
| Jakafi Ruxolitinib Phosphate | 30 | 30 | Under 11 | $507K |
| Levofloxacin Generic | 27 | 39 | Under 11 | $428 |
| Venclexta Venetoclax | 26 | 26 | Under 11 | $39K |
| Iclusig Ponatinib Hcl | 20 | 20 | Under 11 | $455K |
| Posaconazole Generic | 20 | 20 | Under 11 | $9,876 |
| Potassium Chloride Generic | 19 | 19 | Under 11 | $265 |
| Sprycel Dasatinib | 17 | 17 | Under 11 | $132K |
| Calquence Acalabrutinib Maleate | 16 | 16 | Under 11 | $153K |
| Promacta Eltrombopag Olamine | 13 | 13 | Under 11 | $456K |
| Tasigna Nilotinib Hcl | 13 | 13 | Under 11 | $265K |
| Imatinib Mesylate Generic | 12 | 12 | Under 11 | $874 |
| Allopurinol Generic | 11 | 17 | Under 11 | $43.56 |
Brand drugs: 222 claims; generic drugs: 235 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Robin Cook $624 ($624 in general payments such as food, travel and fees) from 10 companies. The largest payer was Abbvie Inc. with $183.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 4 | $183 |
| Astellas Pharma US Inc 4503.T | 3 | $128 |
| PharmaEssentia USA Corporation 6446.TW | 4 | $112 |
| Celgene Corporation BMY | 2 | $46.39 |
| Daiichi Sankyo Inc. 4568.T | 1 | $28.6 |
| Janssen Biotech, Inc. JNJ | 1 | $27.54 |
| Pfizer Inc. PFE | 1 | $26.61 |
| Rigel Pharmaceuticals, Inc. RIGL | 1 | $26.57 |
| Lilly USA, LLC LLY | 1 | $24.7 |
| Adaptive Biotechnologies Corporation ADPT | 1 | $20.19 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.